Cunningham: Strong Signs Ahead For Ophthalmology Innovation

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 004″]

OIS Co-Chair, Emmett T. Cunningham, Jr., MD, recounts the origin of the Ophthalmology Innovation Summits and his time at the formative Eyetech Pharmaceuticals, while sharing in earnest his hopes for ophthalmology as an industry.

Podcast Guest

Emmett Cunningham

Emmett T. Cunningham Jr., MD, PhD, MPH

Dr. Cunningham joined Clarus Ventures with 20+ years in the biomedical and biopharmaceutical sectors. Prior, Dr. Cunningham was the SVP, Medical Strategy at Eyetech Pharmaceuticals. He helped build and lead the team that developed and commercialized Macugen.

View Full Profile

Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the OIS podcast, please complete the application today.

Meet Our Hosts

Ehsan Sadri
ehsan sadri
Firas Rahhal
FirasRahhal
Subscribe

ON iTUNES

Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.